Gujarat Kidney And Super Speciality: The unaudited Standalone and Consolidated financial results for the period ended September 30, 2026
Gujarat Kidney And Super Speciality (GKSL) filed a disclosure titled "The unaudited Standalone and Consolidated financial results for the period ended September 30, 2026". The company is valued at about ₹1,259 crore.
What happened
Gujarat Kidney And Super Speciality (GKSL) filed a disclosure with the exchanges on 4 November 2026 at 06:38 PM titled "The unaudited Standalone and Consolidated financial results for the period ended September 30, 2026".
From the filing: "Gujarat Kidney And Super Speciality Limited has submitted to the Exchange, the unaudited Standalone and Consolidated financial results for the period ended September 30, 2026."
Company snapshot
Gujarat Kidney And Super Speciality is a small-cap company, with a market value of about ₹1,259 crore.
The stock last traded at ₹159.7, against a 52-week range of ₹98.36–₹209.8 (23.9% below the high).
Before this filing the shares had moved −17.1% over the month and +26.1% over three months. Average daily turnover over the last 20 sessions was about ₹12.45 crore.
Promoters held 71.45% at the end of Q1 FY27. Foreign institutions owned 4.88% and domestic institutions 0.56%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q2 FY26 | 28 | 7.5 | 1.47 |
| Q3 FY26 | 23 | 2.9 | 0.52 |
| Q4 FY26 | 31 | 5 | 0.81 |
| Q1 FY27 | 34 | 5.2 | 0.66 |
What history shows
BCEIE's records show 3 previous results filings from the company since May 2026.
After those filings, the stock gained 8.2% on average the next trading day and was up 6.7% on average after five days (3 filings with price data).
Market-wide, 10,609 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 14 Aug 2026 | , the financial results for the period ended Jun 30, 2026. | +12.5% | +11.8% |
| 14 Aug 2026 | Board Meeting Outcome for Outcome Of Board Meeting | +12.5% | +11.8% |
| 28 May 2026 | Financial Results As On 31.03.2026 | −0.4% | −3.6% |
Market reaction so far
Since the filing, the stock has fallen 0.8%, from ₹161.1 before the disclosure to ₹159.7 (last close).
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 4 November 2026: Board meeting — Financial Results.
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.